- Physician's Weekly

Treatment Modality May Reduce Obesity in Patients With Schizophrenia

Mar 2, 2024

Accelerated continuous theta burst stimulation (cTBS) shows promise in reducing obesity and impulsivity among individuals with schizophrenia.

Plant-Based Diet May Benefit People With Genetic Risk for Obesity

Mar 2, 2024

For those genetically predisposed to obesity, a plant-based diet, especially low meat intake, may aid nutrition interventions, impacting obesity outcomes.

Low-Fat Diet Cuts Fatigue in Patients With MS

Mar 2, 2024

A 12-week low-fat diet reduced fatigue in MS; active group showed a 4.0 decrease in Modified Fatigue Impact Scale compared to controls.

Geographic Disparities Impact Access to MS Care

Mar 2, 2024

Disparities in geographic access to neurologic care persist, with rural and micropolitan areas facing lower access; various demographic factors influence accessibility.

ECOG Performance Status Linked With Survival in NSCLC

Mar 2, 2024

In metastatic NSCLC patients receiving immunotherapy, racial/ethnic groups have similar outcomes; ECOG performance status correlates with survival.

10-Year Lung Cancer-Specific Survival for Low-Dose CT Persists

Mar 2, 2024

Two decades of annual low-dose CT screening in the I-ELCAP cohort reveal a sustained 80% lung cancer-specific survival rate, updating the cure rate.

Transition to Neoadjuvant Therapy for Resectable NSCLC Safe & Feasible

Mar 2, 2024

The transition to neoadjuvant therapy in resectable NSCLC is safe and feasible, with comparable complication rates to upfront surgery.

Grading System May Distinguish Course of Adjuvant Chemotherapy

Mar 2, 2024

The IASCL grading system predicts outcomes in resected lung adenocarcinomas, with grade 3 tumors showing aggressiveness and benefiting from adjuvant chemotherapy.

Social Deprivation Index Identifies Disparities in Liver Transplant

Mar 2, 2024

The SDI assesses disparities in living donor liver transplantation, revealing lower disadvantage in recipients than deceased donor transplants.

Artificial Network Beneficial for Predicting Early Graft Failure

Mar 2, 2024

ANN algorithm predicts early graft failure in adult-to-adult living donor liver transplantation using donor and recipient variables, with validated accuracy.

Left Hemihepatectomy Reduces Recurrence in HCC Vs Lobectomy

Mar 2, 2024

Left hemihepatectomy reduces early/intrahepatic recurrence in hepatocellular carcinoma near the left portal vein vs liver lobectomy, with higher 5-year survival.

CT Imaging May Be Biomarker for Predicting HCC Recurrence

Mar 2, 2024

CT patterns indicating aggressive growth are potential biomarkers for hepatocellular carcinoma recurrence post-liver transplant, validated by a reliable nomogram.

Assessment Effectively Measures Visual Function in Retinitis Pigmentosa

Mar 2, 2024

MRDQ domains strongly correlate with visual function in retinitis pigmentosa, validating their use in assessing quality of life.

ABCA-4 Reclassification Includes More Variants of Uncertain Significance

Mar 2, 2024

A classification of 2,246 ABCA4 gene variants, including 1,248 pathogenic, improves diagnosis and counseling for ABCA4-associated retinopathy.

Recombinant Vaccine Confers More Protection Against Influenza

Mar 2, 2024

High-dose recombinant influenza vaccine shows 15.3% higher effectiveness than standard dose in adults aged 50-64, per study in New England Journal of Medicine.

Two Doses of Recombinant Zoster Vaccine Highly Effective

Mar 2, 2024

Two doses of recombinant zoster vaccine (RZV) are effective against herpes zoster, with 76% efficacy, supporting the recommendation for a second dose.

Most Hospitals Employ Core Elements of Antibiotic Stewardship

Mar 2, 2024

Most acute care hospitals adopt the seven Core Elements of Antibiotic Stewardship Programs, showing significant improvement from 41% in 2014 to 95% in 2021.